Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Foresee Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,768	11,995	13,062	10,797	14,047	10,474
Market Cap Growth	-12.68%	-8.16%	20.98%	-23.14%	34.12%	79.10%
Enterprise Value	11,072	11,645	11,754	9,869	12,654	10,323
Last Close Price	76.00	77.50	96.18	90.37	118.16	88.59
Forward PE	-	-	-	-	-	18.90
PS Ratio	26.58	28.65	66.97	35.81	62.15	45.45
PB Ratio	12.11	7.50	10.50	11.86	10.64	5.73
P/TBV Ratio	13.73	8.10	11.69	14.03	12.06	6.47
EV/Sales Ratio	25.01	27.81	60.27	32.73	55.98	44.80
Debt / Equity Ratio	0.25	0.16	0.18	0.05	0.01	0.07
Asset Turnover	0.28	0.21	0.12	0.21	0.12	0.15
Inventory Turnover	1.34	1.15	0.54	0.25	1.73	1.54
Quick Ratio	2.37	3.63	2.65	5.54	17.12	13.45
Current Ratio	2.92	4.62	3.38	7.08	17.51	13.87
Return on Equity (ROE)	-143.98%	-76.04%	-96.17%	-42.38%	-36.15%	-37.48%
Return on Assets (ROA)	-55.10%	-33.57%	-39.79%	-19.92%	-18.00%	-19.49%
Return on Capital (ROIC)	-71.41%	-40.51%	-51.95%	-25.64%	-20.43%	-21.13%
Earnings Yield	-12.06%	-9.01%	-7.93%	-4.38%	-4.05%	-4.88%
FCF Yield	-12.60%	-11.03%	-7.15%	-2.70%	-1.57%	-6.57%
Buyback Yield / Dilution	-7.75%	-7.89%	-7.82%	-0.57%	-15.74%	-5.71%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.